Table of Contents

Articles

• You have access

  Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction

  JUN YAMAMOTO, YUSUKE AOKI, SACHIKO INUBUSHI, QINGHONG HAN, KAZUYUKI HAMADA, YOSHIHIKO TASHIRO, KENTARO MIYAKE, RYUSEI MATSUYAMA, MICHAEL BOUVET, STEVEN G. CLARKE, ITARU ENDO and ROBERT M. HOFFMAN

  Cancer Genomics & Proteomics January 2022, 19 (1) 12-18; DOI: https://doi.org/10.21873/cgp.20299
• You have access

  Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells

  TANIN ZADEH, MARIANA LUCERO and RAJ P. KANDPAL

  Cancer Genomics & Proteomics January 2022, 19 (1) 19-26; DOI: https://doi.org/10.21873/cgp.20300
• You have access

  Novel Contribution of Long Non-coding RNA MEG3 Genotype to Prediction of Childhood Leukemia Risk

  JEN-SHENG PEI, WEN-SHIN CHANG, CHAO-CHUN CHEN, MEI-CHIN MONG, SHIH-WEI HSU, PEI-CHEN HSU, YUAN-NIAN HSU, YUN-CHI WANG, CHIA-WEN TSAI and DA-TIAN BAU

  Cancer Genomics & Proteomics January 2022, 19 (1) 27-34; DOI: https://doi.org/10.21873/cgp.20301
• You have access

  Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells

  DARAPORN CHUA-ON, TANAKORN PROUNGVITAYA, ANCHALEE TECHASEN, TEMDUANG LIMPAIBOON, SITTIRUK ROYTRAKUL, DOUNGDEAN TUMMANATSAKUN, NORIE ARAKI and SIRIPORN PROUNGVITAYA

  Cancer Genomics & Proteomics January 2022, 19 (1) 35-49; DOI: https://doi.org/10.21873/cgp.20302
• You have access

  SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines

  SO YOUNG CHOI, JU MI JEON, ANN YAE NA, OH KWANG KWON, IN HYUK BANG, YUN-SOK HA, EUN JU BAE, BYUNG-HYUN PARK, EUN HYE LEE, TAE GYUN KWON, JUN NYUNG LEE and SANGKYU LEE

  Cancer Genomics & Proteomics January 2022, 19 (1) 50-59; DOI: https://doi.org/10.21873/cgp.20303
• You have access

  Revisiting the Implications of Positive Germline Testing Results Using Multi-gene Panels in Breast Cancer Patients

  GEORGIOS N. TSAOUSIS, EIRINI PAPADOPOULOU, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, NIKOLAOS TSOULOS, IOANNIS BOUKOVINAS, THEOFANIS FLOROS, RODONIKI IOSIFIDOU, OURANIA KATOPODI, ANNA KOUMARIANOU, CHRISTOS MARKOPOULOS, KONSTANTINOS PAPAZISIS, VASILEIOS VENIZELOS, ACHILLEAS KAPSIMALIS, GRIGORIOS XEPAPADAKIS, AMANDA PSYRRI, EUGENIU BANU, DAN TUDOR ENIU, ALEXANDRU BLIDARU, DANA LUCIA STANCULEANU, ANDREI UNGUREANU, VAHIT OZMEN, SUALP TANSAN, MEHMET TEKINEL, SUAYIB YALCIN and GEORGE NASIOULAS

  Cancer Genomics & Proteomics January 2022, 19 (1) 60-78; DOI: https://doi.org/10.21873/cgp.20304
• You have access

  Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab

  BASMA M. SHARAF, ALEXANDER D. GIDDEY, HASAN ALNISS, HAMZA M. AL-HROUB, RAAFAT EL-AWADY, MUATH MOUSA, AHMED ALMEHDI, NELSON C. SOARES and MOHAMMAD H. SEMREEN

  Cancer Genomics & Proteomics January 2022, 19 (1) 79-93; DOI: https://doi.org/10.21873/cgp.20305
• You have access

  Molecular Markers for Long-term Survival in Stage IIIA (N2) NSCLC Patients

  ANCA NASTASE, SIMONA O. DIMA, AUDREY LUPO, VICTORIA LASZLO, REBECCA TAGETT, SORIN DRAGHICI, MONICA ELIA GEORGESCU, ALEXANDRU NECHIFOR, SORIN BERBECE, IRINEL POPESCU, MARCO ALIFANO, WALTER KLEPETKO and MADALINA GRIGOROIU

  Cancer Genomics & Proteomics January 2022, 19 (1) 94-104; DOI: https://doi.org/10.21873/cgp.20306
• You have access

  High Frequency of Juxtamembrane Domain ERBB2 Mutation in Gastric Cancer

  SUJIN PARK, SOOMIN AHN, DEOK GEUN KIM, HYUNJIN KIM, SO YOUNG KANG and KYOUNG-MEE KIM

  Cancer Genomics & Proteomics January 2022, 19 (1) 105-112; DOI: https://doi.org/10.21873/cgp.20307